Literature DB >> 15201768

Trauma as the cause of Peyronie's disease: penile fracture as a model of trauma.

Javaad Zargooshi1.   

Abstract

PURPOSE: This study was performed to determine whether patients with penile fracture or a long history of forcefully bending the erect penis (taqaandan), as models of acute and chronic penile trauma, had an increased rate of Peyronie's disease (PD).
MATERIALS AND METHODS: The study included 193 surgical cases of penile fracture (average followup 85 months), 150 cases of long history of taqaandan, and 50 cases of PD. All 3 groups of patients were interviewed and physically examined.
RESULTS: Signs of PD were found in only 1 case of long-term taqaandan and in no case of penile fracture. None of the 50 cases of PD had a history of penile fracture.
CONCLUSIONS: Severe, acute trauma of penile fracture and moderate, chronic buckling injury of taqaandan are not associated with later development of PD. These findings question whether the hypothesis that trauma, trauma-induced smoldering inflammatory cascade and aberrant wound healing are the main causes of PD. Alternative, plausible, evidence based explanations should be sought for the etiology of PD. Any theory on the etiology of PD should provide an explanation for total lack of occurrence of PD following the trauma of penile fracture.

Entities:  

Mesh:

Year:  2004        PMID: 15201768     DOI: 10.1097/01.ju.0000132144.71458.86

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  14 in total

1.  [Peyronie's disease: diagnostics and therapy].

Authors:  A Hauptmann; T Diemer; W Weidner
Journal:  Urologe A       Date:  2011-05       Impact factor: 0.639

Review 2.  Pharmacological Management of Peyronie's Disease.

Authors:  Landon W Trost; Serap Gur; Wayne J G Hellstrom
Journal:  Drugs       Date:  2007       Impact factor: 9.546

3.  Upregulation of mRNA expression of MCP-1 by TGF-beta1 in fibroblast cells from Peyronie's disease.

Authors:  Carolin Szardening-Kirchner; Lutz Konrad; Ekkehard W Hauck; Simone M Haag; Oliver Eickelberg; Wolfgang Weidner
Journal:  World J Urol       Date:  2008-08-14       Impact factor: 4.226

4.  Effectiveness of antioxidants (propolis, blueberry, vitamin E) associated with verapamil in the medical management of Peyronie's disease: a study of 151 cases.

Authors:  G Paulis; R D'Ascenzo; P Nupieri; G De Giorgio; G Orsolini; T Brancato; R Alvaro
Journal:  Int J Androl       Date:  2011-09-27

5.  Clinical and epidemiological characteristics of young patients with Peyronie's disease: a retrospective study.

Authors:  Gianni Paulis; Giorgio Cavallini; Davide Barletta; Paolo Turchi; Antonio Vitarelli; Andrea Fabiani
Journal:  Res Rep Urol       Date:  2015-07-09

6.  Tunica albuginea allograft: a new model of LaPeyronie's disease with penile curvature and subtunical ossification.

Authors:  Ludovic Ferretti; Thomas M Fandel; Xuefeng Qiu; Haiyang Zhang; Hazem Orabi; Alex K Wu; Lia Banie; Guifang Wang; Guiting Lin; Ching-Shwun Lin; Tom F Lue
Journal:  Asian J Androl       Date:  2014 Jul-Aug       Impact factor: 3.285

Review 7.  Penile fracture epidemiology, diagnosis and management in Iran: a narrative review.

Authors:  Majid Mirzazadeh; Morteza Fallahkarkan; Jalil Hosseini
Journal:  Transl Androl Urol       Date:  2017-04

Review 8.  Molecular Mechanisms and Current Pharmacotherapy of Peyronie's Disease: A Review.

Authors:  Fuxun Zhang; Feng Qin; Jiuhong Yuan
Journal:  Front Pharmacol       Date:  2021-05-20       Impact factor: 5.810

9.  Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study.

Authors:  Gianni Paulis; Davide Barletta; Paolo Turchi; Antonio Vitarelli; Giuseppe Dachille; Andrea Fabiani; Romano Gennaro
Journal:  Res Rep Urol       Date:  2015-12-31

10.  Peyronie's disease after urethral swab, an unusual complication: a case report.

Authors:  Gianni Paulis; Davide Barletta
Journal:  Res Rep Urol       Date:  2015-11-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.